Research on Novel Biomarkers for Early Diagnosis of Parkinson's Disease:An Observational, Multicenter, Non-Randomized Controlled Study

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Parkinson's Disease
Interventions
DIAGNOSTIC_TEST

α- Synuclein Ultrafine Fluorescence Detection Method

This technology belongs to the detection of a-syn aggregates in extracranial tissues, which can replace brain biopsy operations that are difficult to carry out clinically, thus breaking through the limitations of clinical experience in diagnosing a-synuclein lineage diseases and greatly improving the diagnostic and differential diagnostic level of this group of diseases.

Trial Locations (1)

530000

RECRUITING

Guangxi Medical University, Nanning

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine

UNKNOWN

collaborator

Guilin Medical College

OTHER

collaborator

Guangxi International Zhuang Medical Hospital

UNKNOWN

lead

Yousheng Xiao

OTHER